id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-P-6044-0006,FDA,FDA-2019-P-6044,Agency Response Letter from FDA CDER to Latham and Watkins LLP,Other,Agency Response,2020-04-24T04:00:00Z,2020,4,2020-04-24T04:00:00Z,,2020-04-24T17:23:38Z,,0,0,09000064844d3255
FDA-2019-P-6044-0004,FDA,FDA-2019-P-6044,"Exhibit 1 Safety of Epinephrine in Higher Doses re Citizen Petition from Latham & Watkins LLP on behalf of Par Sterile Products, LLC",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T15:03:58Z,,0,0,09000064842512ce
FDA-2019-P-6044-0003,FDA,FDA-2019-P-6044,Acknowledgment Letter from FDA DMS to Latham and Watkins LLP,Other,Acknowledgement Letter/Receipt,2019-12-26T05:00:00Z,2019,12,2019-12-26T05:00:00Z,,2019-12-26T21:26:21Z,,0,0,0900006484252119
FDA-2019-P-6044-0002,FDA,FDA-2019-P-6044,Acknowledgment Letter from FDA DMS to Latham & Watkins LLP,Other,Acknowledgement Letter/Receipt,2019-12-26T05:00:00Z,2019,12,2019-12-26T05:00:00Z,,2019-12-26T21:18:52Z,,0,0,09000064842512a2
FDA-2019-P-6044-0001,FDA,FDA-2019-P-6044,"Citizen Petition from Latham & Watkins LLP on behalf of Par Sterile Products, LLC",Other,Citizen Petition,2019-12-26T05:00:00Z,2019,12,2019-12-26T05:00:00Z,,2020-04-24T17:23:55Z,,0,0,090000648425101c